FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

62018011000036107: benzydamine hydrochloride 1.5 mg + cetylpyridinium chloride monohydrate 1.33 mg + pholcodine 5.5 mg lozenge (medicinal product unit of use)

    Status: retired, Primitive. Date: 30-Jun 2023. Module: Australian Medicines Terminology module

    Descriptions:

    Id Description Lang Type Status Case? Module
    380173011000036116 benzydamine hydrochloride 1.5 mg + cetylpyridinium chloride monohydrate 1.33 mg + pholcodine 5.5 mg lozenge (medicinal product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
    380174011000036119 benzydamine hydrochloride 1.5 mg + cetylpyridinium chloride monohydrate 1.33 mg + pholcodine 5.5 mg lozenge en Synonym Active Case sensitive Australian Medicines Terminology module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    benzydamine hydrochloride 1.5 mg + cetylpyridinium chloride monohydrate 1.33 mg + pholcodine 5.5 mg lozenge Is a benzydamine + cetylpyridinium + pholcodine false Inferred relationship Some
    benzydamine hydrochloride 1.5 mg + cetylpyridinium chloride monohydrate 1.33 mg + pholcodine 5.5 mg lozenge has intended active ingredient benzydamine false Inferred relationship Some 1560444508
    benzydamine hydrochloride 1.5 mg + cetylpyridinium chloride monohydrate 1.33 mg + pholcodine 5.5 mg lozenge has Australian BoSS benzydamine hydrochloride false Inferred relationship Some 1560444508
    benzydamine hydrochloride 1.5 mg + cetylpyridinium chloride monohydrate 1.33 mg + pholcodine 5.5 mg lozenge has intended active ingredient cetylpyridinium false Inferred relationship Some 1886308065
    benzydamine hydrochloride 1.5 mg + cetylpyridinium chloride monohydrate 1.33 mg + pholcodine 5.5 mg lozenge has Australian BoSS cetylpyridinium chloride monohydrate false Inferred relationship Some 1886308065
    benzydamine hydrochloride 1.5 mg + cetylpyridinium chloride monohydrate 1.33 mg + pholcodine 5.5 mg lozenge has intended active ingredient pholcodine false Inferred relationship Some 432336532
    benzydamine hydrochloride 1.5 mg + cetylpyridinium chloride monohydrate 1.33 mg + pholcodine 5.5 mg lozenge has Australian BoSS pholcodine false Inferred relationship Some 432336532
    benzydamine hydrochloride 1.5 mg + cetylpyridinium chloride monohydrate 1.33 mg + pholcodine 5.5 mg lozenge has manufactured dose form lozenge false Inferred relationship Some
    benzydamine hydrochloride 1.5 mg + cetylpyridinium chloride monohydrate 1.33 mg + pholcodine 5.5 mg lozenge has unit of use lozenge false Inferred relationship Some
    benzydamine hydrochloride 1.5 mg + cetylpyridinium chloride monohydrate 1.33 mg + pholcodine 5.5 mg lozenge Is a pholcodine 5.5 mg + cetylpyridinium chloride monohydrate 1.33 mg lozenge false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Difflam Cough Lozenge blackcurrant sugar free lozenge Is a False benzydamine hydrochloride 1.5 mg + cetylpyridinium chloride monohydrate 1.33 mg + pholcodine 5.5 mg lozenge Inferred relationship Some
    benzydamine hydrochloride 1.5 mg + cetylpyridinium chloride monohydrate 1.33 mg + pholcodine 5.5 mg lozenge, 24 has MPUU False benzydamine hydrochloride 1.5 mg + cetylpyridinium chloride monohydrate 1.33 mg + pholcodine 5.5 mg lozenge Inferred relationship Some

    Reference Sets

    Concept inactivation indicator reference set

    REPLACED BY association reference set

    Back to Start